Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
ActiveAtlas Opportunity Score 88/100
2025-REQ-147Mississippi

Mississippi Breast and Cervical Cancer Program Provider Fee For Service Contract, 2025-REQ-147

FundingFee-for-service provider agreement; no provider-specific maximum award is stated on the controlling public procurement index.
DeadlineMarch 31, 2027; official public index does not state a closing clock time or time zone
Last verifiedSeptember 19, 2026
Required next actionQualified Mississippi healthcare providers should review the live MSDH/OpenGov project, current RFA, fee schedules, forms and addendum before applying. Atlas should identify appropriately licensed eligible Mississippi providers for organization-specific evaluation and outreach, subject to all send gates and deduplication.

Broad Eligibility

Appropriately licensed Mississippi healthcare providers and facilities able to furnish MS-BCCP-authorized screening, diagnostic, pathology, imaging, surgical or related services and comply with program contracting, documentation, audit and reimbursement requirements.

Atlas Analysis

N9+ Fit Score 8/100. Strong applicant-side provider-network opportunity for qualified Mississippi FQHCs, RHCs, hospitals, clinics and diagnostic providers. Dr. Miltie/QC direct-provider eligibility is not established on current verified qualifications.

Opportunity Overview

The Mississippi State Department of Health (MSDH) has an open, non-competitive Request for Applications for healthcare providers to participate in the Mississippi Breast and Cervical Cancer Program (MS-BCCP) provider network. The official MSDH OpenGov project index lists 2025-REQ-147 as Open with one addendum and a due date of March 31, 2027. The public index does not display a closing clock time or time zone, so Atlas does not infer one.

Eligible Providers and Services

Provider roles include primary screening providers and qualified secondary or auxiliary providers such as OB/GYNs, surgeons, mammography facilities, hospitals and outpatient surgery facilities, radiologists, pathology/laboratory facilities, anesthesiologists, and CRNAs. Primary providers furnish program-authorized breast and cervical cancer screening, counseling and health education and are responsible for determining participant eligibility and timely enrollment. Contracted providers must follow MS-BCCP program policies, applicable licensure rules, medical-record and audit requirements, referral requirements, and approved screening and diagnostic procedures.

Funding and Reimbursement

This is a fee-for-service provider agreement rather than a fixed grant award. Public solicitation indexing reports a program funding pool of up to approximately $1 million annually, but the controlling MSDH public project index does not state a provider-specific maximum award, so Atlas does not present that figure as an official ceiling. Reimbursement is limited to approved procedures and is not to exceed applicable CMS Medicare Part B participating-provider rates. MS-BCCP is payer of last resort for eligible uninsured and underinsured participants.

Requirements and Documentation

Program documentation includes Screening/Intake Form 718, Consent/Release of Information Form 701, applicable mammogram vouchers and breast/cervical follow-up referral forms, clinical notes and results. Laboratories used for covered pathology must be CLIA-certified. Providers billing under separate tax identification numbers must hold their own MS-BCCP contract. Claims and supporting documentation generally must be submitted within 45 days of service, with special fiscal-year closeout timing for June services. General contract correspondence is directed to bccpcontracts@msdh.ms.gov.

Submission, Addendum and Verification

Applications are accepted through the MSDH procurement/OpenGov process. The official project index currently reports one addendum. Applicants should review the live project, the RFA, fee schedules, forms and the current addendum before submission because those controlling documents govern eligibility and contract terms. Official procurement index: https://procurement.opengov.com/portal/embed/msdh/project-list?departmentId=all&status=all

Atlas Analysis

N9+ Fit Score: 8/100. The Nonagon N9+ remote physical examination platform is not itself a reimbursable breast/cervical cancer screening or diagnostic procedure under this provider contract. Its guided exams, vitals and telehealth-enabled encounter capability may have ancillary value in access or navigation workflows, but Atlas does not treat N9+ acquisition as an allowable contract cost without express MSDH authorization.

Atlas Opportunity Score: 88/100 for appropriately licensed Mississippi healthcare providers. The long enrollment window, statewide need and non-competitive provider-network structure make this strategically useful for qualified Mississippi FQHCs, RHCs, hospitals, clinics, mobile health providers and specialty diagnostic providers. Dr. Miltie, LLC and QC Healthcare are not being represented as direct eligible clinical providers because the required Mississippi provider licensure, facility credentials and program contracting qualifications have not been verified.

Last verified: September 19, 2026.

Source verificationReferenced source · procurement.opengov.comAtlas last verified this record September 19, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗